Search Results - "HO, A. Y. L"

Refine Results
  1. 1
  2. 2

    Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience by Krishnamurthy, P, Lim, Z Y, Nagi, W, Kenyon, M, Mijovic, A, Ireland, R, Marsh, J, Ho, A Y L, Mufti, G J, Pagliuca, A

    Published in Bone marrow transplantation (Basingstoke) (01-10-2010)
    “…Haematopoietic SCT (HSCT) offers the only potentially curative option in chronic myelomonocytic leukaemia (CMML). In this study, we report on single-centre…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab by Moses, S.E., Lim, Z.Y., Sudhanva, M., Devereux, S., Ho, A.Y.L., Pagliuca, A., Zuckerman, M., Mufti, G.J.

    Published in Journal of medical virology (01-12-2006)
    “…Individuals with past exposure to hepatitis B virus (HBV) may reactivate HBV following bone marrow transplantation. Alemtuzumab (CAMPATH)‐based reduced…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cardiac presentation of ALK positive anaplastic large cell lymphoma by Lim, Z. Y., Grace, R., Salisbury, J. R., Creamer, D., Jayaprakasam, A., Ho, A. Y. L., Devereux, S., Mufti, G. J., Pagliuca, A.

    Published in European journal of haematology (01-12-2005)
    “…:  Cardiac involvement as an initial presentation of malignant lymphoma is a rare occurrence. We report the case of an immunocompetent 29‐year‐old male who…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions by HO, A. Y. L, DEVEREUX, S, MUFTI, G. J, PAGLIUCA, A

    Published in Bone marrow transplantation (Basingstoke) (01-04-2003)
    “…The indolent non-Hodgkin's lymphomas are theoretically curable through allogeneic haematopoietic stem cell transplantation (allo-HSCT). The applicability of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis by Nagi, W, Lim, Z.Y, Krishnamurthy, P, Potter, V, Tindell, V, Reiff-Zall, L, Abdullah, A, Lea, N, Kenyon, M, Marsh, J, Ho, A.Y.L, Mufti, G.J, Pagliuca, A

    Published in Leukemia research (01-08-2011)
    “…Abstract We report the results of 11 patients myelofibrosis, who have received a uniform alemtuzumab-based RIC HSCT. The median recipient age was 51 years…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Geographical distribution of red and green Noctiluca scintillans by Harrison, P. J., Furuya, K., Glibert, P. M., Xu, J., Liu, H. B., Yin, K., Lee, J. H. W., Anderson, D. M., Gowen, R., Al-Azri, A. R., Ho, A. Y. T.

    “…The dinoflagellate Noctiluca scintillans is one of the most important and abundant red tide organisms and it is distributed world-wide. It occurs in two forms…”
    Get full text
    Journal Article
  18. 18

    Response to Peggs et al by Ho, A Y L, Devereux, S, Pagliuca, A, Mufti, G J

    Published in Bone marrow transplantation (Basingstoke) (01-04-2003)
    “…Bone Marrow Transplantation (2003) 31, 727. doi:10.1038/sj.bmt.1703894…”
    Get full text
    Journal Article
  19. 19

    Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome by HO, A. Y. L, ADAMS, S, SHAIKH, H, PAGLIUCA, A, DEVEREUX, S, MUFTI, G. J

    Published in Bone marrow transplantation (Basingstoke) (01-05-2002)
    “…Post-transplant lymphoproliferative disorders (PTLD) are a well recognised complication of conventional haemopoietic stem cell transplantation (HSCT). Reduced…”
    Get full text
    Journal Article
  20. 20